SCHEMBL4884972

SCHEMBL4884972

CCCC(=O)OCN1C(C)=C(C(=O)O)C(C)(c2cccc(Cl)c2Cl)C(C(=O)O)=C1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 2/20 0.42
KDM4E B2RXH2 4/20 0.33
CYP2C9 P11712 3/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
LMNA P02545 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 3/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
HIF1A Q16665 2/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 1/20 0.33
TP53 P04637 1/20 0.33
CYP2D6 P10635 1/20 0.33
NFKB1 P19838 1/20 0.33
THPO P40225 1/20 0.33
NR1I2 O75469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424308 0.91 ALDH1A1 (0.38) ABCB11KDM4ECYP2C9MEN1KMT2A
SCHEMBL7418565 0.87 CYP2C9 (0.33) ABCB11KDM4ECYP2C9MEN1KMT2A
SCHEMBL2365028 0.83 TSHR (0.37) ABCB11KDM4ECYP2C9MEN1KMT2A
SCHEMBL3393583 0.76 TSHR (0.40) KDM4ECYP2C9MEN1KMT2ALMNA
SCHEMBL4758577 0.70 TSHR (0.36) ABCB11KDM4ECYP2C9MEN1KMT2A
SCHEMBL9101372 0.66 TSHR (0.37) ABCB11KDM4ECYP2C9MEN1KMT2A
SCHEMBL9033489 0.66 CYP2C9 (0.31) ABCB11KDM4ECYP2C9MEN1KMT2A
SCHEMBL4758043 0.66 CRHBP (0.40) KDM4ECYP2C9MEN1KMT2ALMNA
SCHEMBL30516327 0.65 PYGL (0.34) ABCB11ABCB1ADORA3ADRB3TBXA2R
SCHEMBL7210502 0.65 ABCB11 (0.64) ABCB11KDM4ECYP2C9MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080095841-A1 Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition EISAI R&D MANAGEMENT CO., LTD. (JP) 2008-04-24 US disclosed
EP-1813274-A1 MEDICINAL COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND METHOD OF STABILIZING DIHYDROPYRIDINE COMPOUND IN MEDICINAL COMPOSITION Eisai R&D Management Co., Ltd. (JP) 2007-08-01 EP disclosed
EP-1133473-A1 NEW MANUFACTURING PROCESS AstraZeneca AB (SE) 2001-09-19 EP disclosed
WO-2000031035-A1 NEW MANUFACTURING PROCESS ASTRAZENECA AB (SE) 2000-06-02 WO disclosed